In vitro and in vivo modifications of recombinant and human IgG antibodies
- 3 September 2014
- journal article
- review article
- Published by Taylor & Francis Ltd in mAbs
- Vol. 6 (5), 1145-1154
- https://doi.org/10.4161/mabs.29883
Abstract
Tremendous knowledge has been gained in the understanding of various modifications of IgG antibodies, driven mainly by the fact that antibodies are one of the most important groups of therapeutic molecules and because of the development of advanced analytical techniques. Recombinant monoclonal antibody (mAb) therapeutics expressed in mammalian cell lines and endogenous IgG molecules secreted by B cells in the human body share some modifications, but each have some unique modifications. Modifications that are common to recombinant mAb and endogenous IgG molecules are considered to pose a lower risk of immunogenicity. On the other hand, modifications that are unique to recombinant mAbs could potentially pose higher risk. The focus of this review is the comparison of frequently observed modifications of recombinant monoclonal antibodies to those of endogenous IgG molecules.Keywords
This publication has 143 references indexed in Scilit:
- The Identification of Free Cysteine Residues Within Antibodies a Potential Role for Free Cysteine Residues in Covalent Aggregation Because of Agitation StressJournal of Pharmaceutical Sciences, 2013
- Controlling glycation of recombinant antibody in fed‐batch cell culturesBiotechnology & Bioengineering, 2011
- Advanced glycation endproducts: from precursors to RAGE: round and round we goAmino Acids, 2010
- Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibodyProtein Science, 2009
- Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRnProtein Science, 2009
- Human IgG2 Antibody Disulfide Rearrangement in VivoOnline Journal of Public Health Informatics, 2008
- Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for diseaseGlycobiology, 2008
- Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 SubclassOnline Journal of Public Health Informatics, 2008
- Human IgG2 Antibodies Display Disulfide-mediated Structural IsoformsOnline Journal of Public Health Informatics, 2008
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseThe New England Journal of Medicine, 2008